跳至主要内容
临床试验/ACTRN12607000500459
ACTRN12607000500459招募中未知

A randomised controlled trial to compare the efficacy of high flow versus titrated oxygen therapy in the management of ST-segment elevation Myocardial Infarction

Medical Research Institute of New Zealand0 个研究点目标入组 150 人开始时间: 2007年9月28日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 -2147483648 No limit(—)
性别
All

入选标准

  • Present with ST-segment elevation myocardial infarction (STEMI) based on established diagnostic criteria
  • Are at least 18 years of age and competent to provide written informed consent before entering the study. Informed consent must be signed by the study participant.

排除标准

  • Severe Chronic Obstructive Pulmonary Disease (COPD) or other respiratory disease with PaCO2 > 45mm Hg;
  • Previous myocardial infarction;
  • Subjects who are not to be admitted to the coronary care unit;
  • Women who are known to be pregnant;
  • Cardiogenic shock at the time of presentation at hospital;
  • Severe arterial hypoxaemia (oxygen saturation less than/equal to 85%) at time of presentation;
  • Patients enrolled in other cardiology studies.; patients who have had previous treatment with bleomycin.

研究者

相似试验